Upload Avatar (500 x 500)
Jian Dong Huo
huojiandong@gird.cn
Chinese, English
Guangzhou Medical University
Basic Medical Sciences
  • RSC Horizon Prize: Royal Society of Chemistry
  • Awards for Excellence: University of Oxford
  • NDM Departmental Prize: University of Oxford
  • Clarendon Scholarship: University of Oxford
Prevention and treatment of major infectious diseases such as COVID-19, syncytial virus, and influenza
Immunotherapy for solid tumors such as lung cancer
Non-invasive imaging examination research
  • Adaptive advantage of Omicron and its subvariants in COVID-19 antibody and immune response, Jian Dong Huo, 2022
  • Cross-neutralizing antibody CR3022 against SARS-CoV and COVID-19, Jian Dong Huo, 2020
  • Molecular structure of anti-COVID-19 nanobody with Spike and RBD proteins, Jian Dong Huo, 2020
  • Development of next-generation nanobodies against COVID-19 variants, Jian Dong Huo, 2021
Covid-19 Syncytial Virus Influenza Infectious Diseases Immunotherapy Lung Cancer Solid Tumors Non-Invasive Imaging Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.